AGIOS PHARMACEUTICALS, INC. Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for March 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 2.34 | 4,100 | 9,594 | 27,718 | |
| Mar 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 0.47 | 37 | 17 | 1,766 | |
| Mar 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 2.34 | 4,100 | 9,594 | 57,196 | 53.1 K to 57.2 K (+7.72 %) |
| Mar 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 0.47 | 37 | 17 | 53,096 | 53.1 K to 53.1 K (+0.07 %) |
| Mar 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 70,900 | |
| Mar 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 84.65 | 2,050 | 173,533 | 0 | 2.1 K to 0 (-100.00 %) |
| Mar 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
| Mar 21 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | M | 47.33 | 6,800 | 321,844 | 0 | |
| Mar 21 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Sell | S | 81.97 | 6,800 | 557,396 | 2,200 | 9 K to 2.2 K (-75.56 %) |
| Mar 21 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Buy | M | 47.33 | 6,800 | 321,844 | 9,000 | 2.2 K to 9 K (+309.09 %) |
| Mar 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Buy | P | 83.44 | 200 | 16,688 | 571 | 371 to 571 (+53.91 %) |
| Mar 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Buy | P | 83.44 | 200 | 16,688 | 571 | 371 to 571 (+53.91 %) |
| Mar 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 2,000 | 70,320 | 103,000 | |
| Mar 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 82.90 | 300 | 24,870 | 881 | 1.2 K to 881 (-25.40 %) |
| Mar 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 82.23 | 1,700 | 139,791 | 1,181 | 2.9 K to 1.2 K (-59.01 %) |
| Mar 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 2,000 | 70,320 | 2,881 | 881 to 2.9 K (+227.01 %) |
| Mar 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 3,000 | 27,150 | 28,154 | |
| Mar 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 84.10 | 1,100 | 92,510 | 53,059 | 54.2 K to 53.1 K (-2.03 %) |
| Mar 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 83.21 | 1,100 | 91,531 | 54,159 | 55.3 K to 54.2 K (-1.99 %) |
| Mar 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 82.04 | 400 | 32,816 | 55,259 | 55.7 K to 55.3 K (-0.72 %) |
| Mar 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 80.93 | 400 | 32,372 | 55,659 | 56.1 K to 55.7 K (-0.71 %) |
| Mar 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 3,000 | 27,150 | 56,059 | 53.1 K to 56.1 K (+5.65 %) |